Eli Lilly and Company(@EliLillyandCo):A new pathway for access to obesity treatment through Medicare begins July 1. Eligible Medicare Part D patients may be able to get certain medicines for weight management through Medicare GLP-1 Bridge. Learn more and see the CMS Medicare GLP-1 Bridge Clinical Criteria:

Eli Lilly and Company

@EliLillyandCo

Uniting caring with discovery to create medicines that make life better worldwide. Lilly’s official account (formerly LillyPad)

加入 July 2010

1.2K 正在關注 146.1K 粉絲

Eli Lilly and Company@EliLillyandCo

2026.06.25 11:02

A new pathway for access to obesity treatment through Medicare begins July 1. Eligible Medicare Part D patients may be able to get certain medicines for weight management through Medicare GLP-1 Bridge. Learn more and see the CMS Medicare GLP-1 Bridge Clinical Criteria: